T 0507/17 (JANUS KINASE INHIBITORS) of 19.11.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T050717.20201119
- Date of decision
- 19 November 2020
- Case number
- T 0507/17
- Petition for review of
- -
- Application number
- 08770794.9
- IPC class
- A61K 31/519C07D 487/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
- Applicant name
- Incyte Holdings Corporation
- Opponent name
- Actavis Group PTC ehf
Generics [UK] Ltd (trading as Mylan) - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 87 (2007)Rules of procedure of the Boards of Appeal Art 12(2) (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2007)Rules of procedure of the Boards of Appeal Art 13(3) (2007)
- Keywords
- Late-filed objections
Late-filed objection - admitted (no)
Novelty - (yes)
Inventive step - (yes)
Priority - (yes)
Insufficiency of disclosure (no) - Catchword
- -
- Cited cases
- G 0002/98
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form according to the claims of the main request, filed as auxiliary request 2 with letter dated 27 July 2020, and a description to be adapted thereto.